These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37081311)

  • 1. The relaxin receptor RXFP1 signals through a mechanism of autoinhibition.
    Erlandson SC; Rawson S; Osei-Owusu J; Brock KP; Liu X; Paulo JA; Mintseris J; Gygi SP; Marks DS; Cong X; Kruse AC
    Nat Chem Biol; 2023 Aug; 19(8):1013-1021. PubMed ID: 37081311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
    Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
    J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1.
    Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR
    Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).
    Diepenhorst NA; Petrie EJ; Chen CZ; Wang A; Hossain MA; Bathgate RA; Gooley PR
    J Biol Chem; 2014 Dec; 289(50):34938-52. PubMed ID: 25352603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation.
    Hopkins EJ; Layfield S; Ferraro T; Bathgate RA; Gooley PR
    J Biol Chem; 2007 Feb; 282(6):4172-84. PubMed ID: 17148455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
    Sethi A; Bruell S; Ryan T; Yan F; Tanipour MH; Mok YF; Draper-Joyce C; Khandokar Y; Metcalfe RD; Griffin MDW; Scott DJ; Hossain MA; Petrie EJ; Bathgate RAD; Gooley PR
    J Mol Biol; 2021 Oct; 433(21):167217. PubMed ID: 34454945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin.
    Bruell S; Sethi A; Smith N; Scott DJ; Hossain MA; Wu QP; Guo ZY; Petrie EJ; Gooley PR; Bathgate RAD
    Sci Rep; 2017 Jun; 7(1):3294. PubMed ID: 28607406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
    Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
    Scott DJ; Rosengren KJ; Bathgate RA
    Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis.
    Hoare BL; Kocan M; Bruell S; Scott DJ; Bathgate RAD
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00513. PubMed ID: 31384473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the primary hormone-binding site of RXFP1 and RXFP2.
    Scott DJ; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation.
    Kong RC; Bathgate RA; Bruell S; Wade JD; Gooley PR; Petrie EJ
    Biochemistry; 2014 Jul; 53(28):4537-48. PubMed ID: 24983702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.
    Hartley BJ; Scott DJ; Callander GE; Wilkinson TN; Ganella DE; Kong CK; Layfield S; Ferraro T; Petrie EJ; Bathgate RA
    Ann N Y Acad Sci; 2009 Apr; 1160():67-73. PubMed ID: 19416161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a scaffold displaying exoloops of RXFP1.
    Diepenhorst NA; Gooley PR; Stone MJ; Bathgate RA
    Ital J Anat Embryol; 2013; 118(1 Suppl):1-3. PubMed ID: 24640555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1.
    Svendsen AM; Zalesko A; Kønig J; Vrecl M; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):10-7. PubMed ID: 18723073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimerization and negative cooperativity in the relaxin family peptide receptors.
    Svendsen AM; Vrecl M; Knudsen L; Heding A; Wade JD; Bathgate RA; De Meyts P; Nøhr J
    Ann N Y Acad Sci; 2009 Apr; 1160():54-9. PubMed ID: 19416159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.